|
Chris is an Entrepreneur in Residence. Chris joined Bay after 9 years in start-up and mid-size biotechnology. Most recently he was co-founder and research director of EnVivo Pharmaceuticals Inc., a biopharmaceutical company dedicated to discovering and developing drugs for central nervous system disorders. EnVivo has raised approximately $62M in three funding rounds and is due to be in the clinic with its first NCE in 2006. Prior, Chris held research and project leadership positions at AGY Therapeutics Inc., and Genencor International Inc.
Education
B.A., University of California, Santa Barbara
Ph.D., Baylor College of Medicine | 